Jund is a determinant of macrophage activation and is associated with glomerulonephritis susceptibility

Nature Genetics

Volumn 40, Issue 5, 2008, Pages 553-559

  Behmoaras, Jacques ^a   Bhangal, Gurjeet ^a   Smith, Jennifer ^a   McDonald, Kylie ^a   Mutch, Brenda ^b   Lai, Ping Chin ^c   Domin, Jan ^a   Game, Laurence ^a   Salama, Alan ^a   Foxwell, Brian M ^b   Pusey, Charles D ^a   Cook, H Terence ^a   Aitman, Timothy J ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR JUND;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL INFILTRATION; CONGENIC STRAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GENE LOCUS; GENETIC LINKAGE; GLOMERULONEPHRITIS; GLOMERULUS; HAPLOTYPE; HUMAN; INTROGRESSION; MACROPHAGE ACTIVATION; MICROARRAY ANALYSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANIMALS, CONGENIC; CHROMOSOME MAPPING; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GLOMERULONEPHRITIS; HAPLOTYPES; HUMANS; LINKAGE (GENETICS); MACROPHAGE ACTIVATION; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RATS, INBRED LEW; RATS, INBRED WKY; TRANSCRIPTION FACTOR AP-1;

RATTUS;

EID: 42649106487     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.137     Document Type: Article

References (25)

1. Aitman, T.J. et al. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 439, 851-855 (2006).
2. Tam, F.W. et al. Development of scarring and renal failure in a rat model of crescentic glomerulonephritis. Nephrol. Dial. Transplant. 14, 1658-1666 (1999).
3. Smith, J. et al. Genes expressed by both mesangial cells and bone marrow-derived cells underlie genetic susceptibility to crescentic glomerulonephritis in the rat. J. Am. Soc. Nephrol. 18, 1816-1823 (2007).
4. Lai, P.C. et al. Interleukin-11 attenuates nephrotoxic nephritis in Wistar Kyoto rats. J. Am. Soc. Nephrol. 12, 2310-2320 (2001).
5. Cattell, V. Macrophages in acute glomerular inflammation. Kidney Int. 45, 945-952 (1994).
6. Cook, H.T. et al. Interleukin-4 ameliorates crescentic glomerulonephritis in Wistar Kyoto rats. Kidney Int. 55, 1319-1326 (1999).
7. Isome, M. et al. Important role for macrophages in induction of crescentic anti-GBM glomerulonephritis in WKY rats. Nephrol. Dial. Transplant. 19, 2997-3004 (2004).
8. Duffield, J.S. et al. Conditional ablation of macrophages halts progression of crescentic glomerulonephritis. Am. J. Pathol. 167, 1207-1219 (2005).
9. Cook, H.T., Smith, J., Salmon, J.A. & Cattell, V. Functional characteristics of macrophages in glomerulonephritis in the rat. O2- generation, MHC class II expression, and eicosanoid synthesis. Am. J. Pathol. 134, 431-437 (1989).
10. Kluth, D.C. Pro-resolution properties of macrophages in renal injury. Kidney Int. 72, 234-236 (2007).
11. Wang, Y. et al. Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int. 72, 290-299 (2007).
12. Aitman, T.J. et al. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat. Genet. 21, 76-83 (1999).
13. Pravenec, M. et al. Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats. Nat. Genet. 27, 156-158 (2001).
14. Pfarr, C.M. et al. Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras. Cell 76, 747-760 (1994).
15. Weitzman, J.B., Fiette, L., Matsuo, K. & Yaniv, M. JunD protects cells from p53-dependent senescence and apoptosis. Mol. Cell 6, 1109-1119 (2000).
16. Gerald, D. et al. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 118, 781-794 (2004).
17. Sakurai, H. et al. Suppression of NF-kappa B and AP-1 activation by glucocorticoids in experimental glomerulonephritis in rats: molecular mechanisms of anti-nephritic action. Biochim. Biophys. Acta 1362, 252-262 (1997).
18. Sakurai, H. & Sugita, T. c-Jun N-terminal kinase-mediated AP-1 activation in experimental glomerulonephritis in rats. Biochem. Mol. Biol. Int. 45, 831-839 (1998).
19. Flanc, R.S. et al. A pathogenic role for JNK signaling in experimental anti-GBM glomerulonephritis. Kidney Int. 72, 698-708 (2007).
20. Ikezumi, Y., Hurst, L., Atkins, R.C. & Nikolic-Paterson, D.J. Macrophage-mediated renal injury is dependent on signaling via the JNK pathway. J. Am. Soc. Nephrol. 15, 1775-1784 (2004).
21. Meixner, A., Karreth, F., Kenner, L. & Wagner, E.F. JunD regulates lymphocyte proliferation and T helper cell cytokine expression. EMBO J. 23, 1325-1335 (2004).
22. Andersson, A., Kokkola, R., Wefer, J., Erlandsson-Harris, H. & Harris, R.A. Differential macrophage expression of IL-12 and IL-23 upon innate immune activation defines rat autoimmune susceptibility. J. Leukoc. Biol. 76, 1118-1124 (2004).
23. Bhan, A.K., Schneeberger, E.E., Collins, A.B. & McCluskey, R.T. Evidence for a pathogenic role of a cell-mediated immune mechanism in experimental glomerulonephritis. J. Exp. Med. 148, 246-260 (1978).
24. May, R.C., Caron, E., Hall, A. & Machesky, L.M. Involvement of the Arp2/3 complex in phagocytosis mediated by FcγR or CR3. Nat. Cell Biol. 2, 246-248 (2000).
25. Williams, L., Bradley, L., Smith, A. & Foxwell, B. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J. Immunol. 172, 567-576 (2004).